- Open Access
Localization of TrkB and p75 receptors in peritoneal and deep infiltrating endometriosis: an immunohistochemical study
© The Author(s). 2016
- Received: 2 April 2016
- Accepted: 29 July 2016
- Published: 12 August 2016
The roles of the neurotrophins NGF (Neurotrophic growth factor) and BDNF (brain-derived neurotrophic factor) in neuronal growth and development are already known. Meanwhile, the neurotrophin receptors TrkA (tropomyosin related kinase A), TrkB, and p75 are important for determining the fate of cells. In endometriosis, this complex system has not been fully elucidated yet. The aim of this study was to evaluate the expression and location of these neurotrophins and their receptors in peritoneal (PE) and deep infiltrating endometriotic (DIE) tissues and to measure and compare the density of nerve fibers in the disease subtypes.
PE lesions (n = 20) and DIE lesions (n = 22) were immunostained and analyzed on serial slides with anti-BDNF, −NGF, −TrkA, −TrkB, −p75,-protein gene product 9.5 (PGP9.5, intact nerve fibers) and -tyrosine hydroxylase (TH, sympathetic nerve fibers) antibodies.
There was an equally high percentage (greater than 75 %) of BDNF-positive immunostaining cells in both PE and DIE. TrkB (major BDNF receptor) and p75 showed a higher percentage of immunostaining cells in DIE compared to in PE in stroma only (p < 0.014, p < 0.027, respectively). Both gland and stroma of DIE lesions had a lower percentage of NGF-positive immunostaining cells compared to those in PE lesions (p < 0.01 and p < 0.01, respectively), but there was no significant reduction in immunostaining of TrkA in DIE lesions. There was no difference in the mean density of nerve fibers stained with PGP9.5 between PE (26.27 ± 17.32) and DIE (28.19 ± 33.15, p = 0.8). When we performed sub-group analysis, the density of nerves was significantly higher in the bowel DIE (mean 57.33 ± 43.9) than in PE (mean 26.27 ± 17.32, p < 0.01) and non-bowel DIE (mean 14.6. ± 8.6 p < 0.002).
While the neurotrophin BDNF is equally present in PE and DIE, its receptors TrkB and p75 are more highly expressed in DIE and may have a potential role in the pathophysiology of DIE, especially in promotion of cell growth. BDNF has a stronger binding affinity than NGF to the p75 receptor, likely inducing sympathetic nerve axonal pruning in DIE, resulting in the lower nerve fiber density seen.
Endometriosis is diagnosed by the presence of endometrial glands and stroma outside of the uterine cavity. These endometriotic lesions are predominantly found in the pelvis, namely on the peritoneum, ovaries, myometrium of the uterus (adenomyosis) and the bowel. The gold standard for the diagnosis of endometriosis is surgical visualization, which is commonly accomplished with laparoscopy, followed by histological confirmation of operatively excised lesions . Endometriosis can be divided into two subtypes: superficial peritoneal endometriosis (PE) and deep infiltrating (DIE) disease, the latter defined by lesions located at least 5 mm beneath the peritoneal surface. The pathophysiology of DIE, including its development, innervation, and association with inflammation and vascularization, has been the subject of numerous studies. Most, but not all, conclude that these aspects differ between DIE and PE endometriosis [2–4].
In addition, multiple investigators have aimed at elucidating the mechanisms of pain generation in endometriosis to improve the understanding of endometriosis-associated pelvic pain [5, 6]. Previous studies have evaluated for the presence of nerve fibers in endometriotic lesions, comparing the innervation density between PE, DIE and normal peritoneum using specific stains for all intact-nerve fibers (Protein Gene Product 9.5,PGP9.5), sensory nerve fibers-(Substance-P), and sympathetic-nerve fibers (tyrosine hydroxylase) [7, 8]. The studies have found that: (1) there is little difference in overall nerve fiber density between PE and healthy peritoneum and (2) PE lesions have a higher density of sensory nerve fibers and a lower density of sympathetic nerves than healthy peritoneum . In DIE, the density of nerve fibers stained with PGP9.5 was the highest in endometrial lesions taken from rectum compared to the density seen in peritoneal lesions and in DIE lesions taken from other locations such as the uterosacral ligament or the retro-uterine cul de sac. Surprisingly, the nerve fiber density in non-bowel DIE (cul-de-sac and uterosacral ligament lesions) was not different than that observed in peritoneal endometriosis .
The presence of neurotrophins, a family of proteins critical to supporting the growth and differentiation of developing neurons and to maintaining neuronal survival, has been studied in endometriosis . The key components of the neurotrophin system in humans are nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and the neurotrophins-3 (NT-3), −4/5 (NT-4/5)  as well as their respective receptors, the tropomyosin kinase receptors (TrkA, TrkB, TrkC) and the neurotrophin receptor p75, a member of the tumor necrosis factor (TNF) receptor superfamily. Specifically, the Trk receptors consist of: TrkA, the high affinity receptor for NGF and TrkB, the main receptor of BDNF and NT4/5. The binding of NGF and BDNF to the P75 receptor induces survival of the cell while the binding of the premature type of neurotrophin, pro-NGF and pro-BDNF, to the p75 receptor induces apoptosis in the cells [10, 11].
In endometriosis, the expression of NGF was confirmed using immunohistochemistry in the gland, stroma, [12–14] and in nerve fibers of endometriosis lesions [4, 8]. In addition, the concentration of the neurotrophin NGF has been reported by several groups to correlate with the density of nerve fibers, both in PE [4, 13, 14] as well as in DIE, including bowel endometriosis [8, 12, 15]. Furthermore, Anaf et al. reported that NGF expression was higher in the glands and stroma of adenomyosis lesions compared to PE , but interestingly did not differ from endometrium of disease-free controls .
The spatial relationship between the main neurotrophins (NGF and BDNF) and their receptors (TrkA, TrkB, p75) in histological sections from endometriosis tissue has not been extensively studied so far. Tarjanne et al. recently reported that NGF and its receptor TrkA were strongly expressed in rectovaginal endometriosis but they did not make comparisons to PE or DIE from other locations [12, 14]. No studies have evaluated the presence and location of BDNF in endometriosis lesions, although BDNF is present in eutopic endometrium from women with endometriosis.
The main objective of this immunohistochemistry study was to assess for the presence and localization of the neurotrophins NGF and BDNF and their receptors, TrkA and, TrkB and p75, in endometriosis lesions and to compare these between PE and DIE by using quantitative methods. Secondarily, we compared the density of nerve fibers in PE versus non-bowel DIE and bowel DIE.
Clinical characteristics of subjects
Age (mean ± SD)
33.15 ± 5.79
33.54 ± 6.72
Lower abdominal pain
Location of DIE lesion
Bowel (rectum, appendix, colon/sigmoid)
None of the subjects received medical therapy for endometriosis nor hormonal contraception for at least 3 months prior to laparotomy or laparoscopy for the excision of endometriosis. This study was approved by the Ethics Committee of the Medical University of Innsbruck (No. UN5130, July 2nd, 2013) and all patients gave their informed consent for research participation.
All the specimens were immediately fixed in 4 % paraformaldehyde for 12 h, and processed and embedded in paraffin according to standard protocols. Each section was cut at 3 μm thickness for 15 serial sections. Serial sections enabled us to study corresponding spatial/anatomical sites and evaluate the location of neurotrophins as well as their receptors. Routine hematoxylin and eosin (H&E) staining was performed for tissue overviews.
Immunohistochemistry of sections with antibodies directed against NGF, BDNF, TrkA, TrkB, p75, PGP9.5, and TH were performed. Immunohistochemistry was performed with an automated staining system Ventana® Roche® Discovery that ensured precise and equal treatment of each slide. This was a prerequisite for quantification of immunostaining intensities. Sections were immunohistochemically stained with the polyclonal rabbit anti-NGF (dilution: 1:400, sc-548, Santa Cruz Biotechnology, California), polyclonal rabbit anti-BDNF (dilution: 1:1200, ab101752, Abcam, England), polyclonal goat anti-TrkA (dilution: 1:240, sc-20,537 Santa Cruz biotechnology, California) polyclonal rabbit anti-TrkB (dilution: 1:60, sc-8316, Santa Cruz Biotechnology, California), polyclonal rabbit anti p75 (dilution: 1:3200, a gift from Prof. Reichardt, University California San Francisco), polyclonal rabbit anti PGP.9.5 (dilution: 1:2400, ab10404, Abcam, England) monoclonal mouse anti-tyrosine hydroxylase (dilution 1:2000, T1299, Sigma, USA). Healthy human colon and healthy human endometrium were used as positive controls for neurotrophins and receptors. Healthy human skin and healthy human colon were used as positive controls for nerve fibers. Negative controls were treated identically except that the primary antibody was replaced with IgG rabbit or goat isotype for polyclonal antibodies and IgG1 mouse for monoclonal antibody.
For each study participant, one representative gland and area of stroma were identified. Once the immunohistochemistry analysis for that gland and stroma was carried out with a single antibody, it was then carried out on the same gland and stroma in the adjacent section for another antibody. With this method, we could determine the precise localization of the neurotrophins and receptors on the same gland and stroma.
Stained tissue sections were analyzed at × 20 magnification using a Tissuefax Plus system based on a Zeiss® AxioImagerZ2 Microscope (Jena, Germany). Images were acquired with the TissueFaxs (Tissue-Gnostics®, Vienna, Austria) software. The percentage of NGF-, BDNF-, TrkA-, TrkB-, and p75 –positive immunostaining cells in each endometriosis tissue specimen was quantified using HistoQuest® (Tissue-Gnostics) software. This software has been used by previous researchers [17–19] and has the advantage of being more objective than the subjective assessment by an investigator.
Histoquest® is an analytical tool used to quantify immunostaining based on single cells using the cell specific nucleus structure as the primary identification marker (hematoxylin), followed by an automatic segmentation of the immunostaining confined to the corresponding nucleus. A ring mask around this nucleus is interactively defined and set as parameter for all sections stained with a certain marker-specific channel named single reference shade. The brown staining caused by chromogen (3,3’-diaminobenzidine, DAB) is automatically separated from the blue hematoxylin staining into their optical density counterparts. The mean optical density per cell is quantified by the segmentation method.
Regions of interest (ROIs) were defined separately for glandular epithelial tissue and stromal tissue. Identification of cell types was accomplished through morphometric parameters such as the nuclear size, shape and staining intensity. A background threshold for hematoxylin staining was determined interactively. Immunostaining cut-offs were determined as well (this tool differentiates between positive and negative cells; these were set in the dot blots). All images were acquired with the same setting parameters. The representative brown color (DAB chromogen) was picked by the color picker tool. Positive staining cells were shown in the scatter gram of forward gating tool. The raw data of the analysis were imported into SPSS 21.0 (IBM, Armonk, NY, USA) for further statistical analysis. The number of NGF-, BDNF-, TrkA-, TrkB-, and p75 –positive immunostaining cells was divided by the total number of cells in each gland or stroma of endometriosis tissue (hematoxylin counterstain), yielding a percentage of staining. More detailed methodology and setting parameters of Histoquest® can be found in the Supplemental Section (Additional files 1, 2, 3, 4 and 5: Figs. S1, S2, S3, S4 and S5).
Nerve fiber density
Each stained endometriosis section was imaged at × 40 magnification using the above described TissueFaxs Plus systems. The evaluation area was randomly set to 1 mm2 surrounding the nerve fiber located nearest to the lesion. The area of interest was manually highlighted with a tool provided by HistoQuest® software to comprise an area of 1 mm2 as shown in Additional file 6: Fig. S6. Thus, the total nerve fiber density was calculated by averaging the amount of nerve fibers defined by PGP9.5 positive staining in 3 different areas of endometriosis of 1 mm2 each (Additional file 6: Fig. S6). The same method was used to calculate the density TH-positive staining sympathetic nerve fibers.
The Mann-Whitney U test was used to evaluate the difference between the percentage of positive immunostaining cells in PE and DIE. The student’s t-test was used to compare mean nerve fiber density between groups. Pearson correlation was used to analyze the correlation between neurotrophins and the nerve fibers. P < 0.05 was considered statistically significant at 95 % of confidence interval.
Staining for BDNF and TrkB
Staining for NGF and TrkA
Staining for p75
Staining nerve fibers for PGP9.5 in PE, bowel DIE and non-bowel DIE
Staining nerve fibers using TH compared to PGP9.5 in non-bowel DIE
Mean density of sympathetic nerve fibers stained with TH was not different between PE and DIE. When the DIE group was split to bowel and non-bowel endometriosis, the pattern of mean density of nerves for each group stained with TH was similar to that seen with PGP9.5, with markedly higher concentration of sympathetic nerves in bowel DIE, and similarly lower sympathetic innervation of non-bowel DIE and PE (Fig. 4h).
Staining for nerve fibers using PGP9.5 in DIE of bowel (colon)
The correlation between neurotrophin expression and nerve fibers density
We performed correlation analyses between NGF and BDNF immunostaining and nerve fiber density (PGP9.5 staining) for both gland and stroma, and for the subtypes of endometriosis (PE and non-bowel DIE). We chose to exclude bowel DIE in these analyses because of the inability to differentiate between the intrinsic and extrinsic innervation, thus making endometriosis-specific nerve growth impossible to study.
When both subtypes of endometriosis tissues were taken together (PE and DIE), there was no significant correlation between BDNF-positive staining and nerve density assessed by PGP9.5, neither for gland nor stroma (data not shown). When only the gland was assessed, there was a negative correlation seen only in non-bowel DIE (P < 0.007, r = −0.618). We then did analogous correlations for NGF and PGP9.5, BDNF and TH and also NGF and TH.
The correlation between BDNF-positive immunostaining and the density of nerve fibers stained with PGP9.5
BDNF vs PGP9.5
NGF vs PGP9.5
BDNF vs TH
NGF vs TH
Staining for neurons (PGP9.5), p75 and trks receptors in endometriosis in submucosa of colon
The submucosal plexus in the bowel strongly stained with p75 and TrkB antibodies, and faintly stained with TrkA antibody. The submucosal plexus has an important role in innervating mucous glands of the bowel. As depicted in Additional file 7: Fig. S7, endometrial glands were surrounded by small nerve fibers.
Cell growth and development
Based on the high degree of staining for BDNF in both glands and stroma of PE and DIE, this neurotrophin appears to play a role in the innervation of endometriosis. TrkB, the main receptor of BDNF is expressed more highly in glands than in stroma, and highest in the stroma of DIE, but with high variability. The other receptor for BDNF, p75, showed similar expression, namely high expression in glands of PE and DIE, moderate expression in stroma of DIE and relatively low expression in stroma of PE. BDNF mRNA expression has previously been shown in eutopic endometrium of women with endometriosis  and also in normal human and mammalian uterus as well as endometrium (glandular epithelium and stroma) . We confirm, for the first time in histological sections, that BDNF is present in endometriosis lesions, both DIE and in peritoneal lesions.
NGF and BDNF are both important for axonal growth of sensory neurons, but each induces growth of a different type of sensory neuron. In vitro studies in chick dorsal root ganglion showed that neuronal growth cones turned and migrated under NGF-coated beads through the expression of TrkA receptors . Another study showed that visceral afferent neurons in the nodose/petrosal sensory ganglion complex innervated vascular afferents that express high levels of BDNF in the development of arterial baroreceptors. The survival of these neurons was reduced by TrkB-Fc blocking . Analogous mechanisms may be responsible for inducing sensory neuron growth in endometriosis lesions via both TrkA and TrkB.
BDNF and NGF play different roles in sensory nerve development, with BDNF influencing axonal branching and the growth of lathellipodia and NGF influencing axonal elongation of sensory neurons from the dorsal root ganglion . Furthermore, endometriosis is an estrogen-dependent disease in which lesions stimulate their own growth by producing estrogen via aromatase activity  and also via the mechanism of tissue injury and repair . Wessels et al. showed that estrogen exposure may activate BDNF-TrkB pathways in a mouse model, exerting wide ranging effects such as neural development, cell differentiation, growth and maintenance, angiogenesis, proliferation, and resistance to apoptosis . In clinical studies in humans, Wessels et al. reported that that plasma BDNF concentrations were significantly higher in women with endometriosis than in controls, whereas other neurotrophins, NGF and NT4/5, were not different .
It is known that estrogen may have local proliferative actions as well as neuromodulatory effects on the innervation of endometeriosis . In this retrospective study, we were not able to fully account for the menstrual cycle phase at which the histological sample was obtained. However, in a recent report, there was no effect of menstrual cycle phase on circulating BDNF levels in women with endometriosis . In mice, estrogen exposure after ovariectomy significantly increases uterine BDNF, but the hormonal fluctuations of the murine estrous cycle do not . Importantly, none of the women in this study used hormonal medication for at least 3 months prior to sample collection, as hormonal treatment has been shown to decrease the nerve fiber density in peritoneal endometriosis lesions .
We found that NGF was higher in PE than in DIE, in both glands and stroma. Previous studies looked only at endometrioma, adenomyosis, peritoneal lesions [13, 28, 29] and eutopic endometrium from endometriosis patients . The main receptor of NGF, TrkA was not different between PE and DIE in both locations. These results differ from those of Anaf et al. who found that deep adenomyotic lesions had higher expression of NGF immunohistochemically than peritoneal endometriosis  and imply that DIE and adenomyosis are not comparable entities when it comes to neurotrophin expression.
We found a low NGF expression as well as low nerve fiber density in DIE, especially in non-bowel DIE. Perhaps, the loss of NGF-TrkA signaling transduction causes failure of NGF-dependent neuron to survive . Furthermore, in sensory developmental studies, NGF is important for nociceptor development and BDNF is important for mechanoreceptor development . Our results are consistent with those of Arellano et al. who implicated the peritoneum as an important location for pathogenesis and pain generation in endometriosis . Thus, our results support the concept that NGF is involved in neuronal development and likely pain generation from peritoneum in endometriosis [12, 13, 32].
Many studies have evaluated the role of Trk receptors in the invasiveness or degree of progressiveness in cancer. TrkA receptors appear to promote the growth and metastasis in breast cancer [33, 34], while TrkB receptors promote invasion in choriocarcinoma cells . We found that TrkB expression was high in DIE, especially in stromal cells. This pattern is similar to that seen for p75 expression, but not for TrkA expression. This finding could be secondary to an effect of estrogen . Therefore, we speculate that p75 receptor is involved in survival rather than apoptosis in endometriosis.
On first analysis, it appears that there is no difference in mean nerve density between PE and DIE. However, critical differences appear when DIE from bowel and non-bowel locations was evaluated separately, as also shown by Wang . We found that the sub-group of non-bowel DIE endometriosis actually had a lower density of innervation than the PE.
The DIE from bowel showed markedly higher innervation, both total nerve density as well as the density of sympathetic nerves stained with TH. The innervation of bowel is highly complex, stemming from both intrinsic (from the enteric nervous system) as well as extrinsic nerves (from autonomic nervous system—parasympathetic and sympathetic nervous system). In addition, the intestine has sensory afferents originating from the vagus nerve (nodose ganglion) [36, 37] and sensory afferents originating from dorsal root ganglion . A previous study likewise demonstrated that normal bowel has a rich innervation base on nerve fiber density area stained with PGP9.5 and other markers [39, 40]. The plexus of Auerbach and Meissner (submucosal plexus) likewise express PGP9.5, and may be damaged by the invasion of an endometriosis lesion, as we also showed [41–43]. Thus, it is very difficult and likely error-prone to compare the endometriosis-influenced innervation of PE to bowel endometriosis because the intrinsic and extrinsic innervations of bowel cannot be differentiated with immunohistochemistry. In future studies, investigators should focus on DIE from non-bowel sources when making comparisons to PE.
Correlation between cell expressing neurotrophins and the nerve fibers density
BDNF showed a negative correlation to total nerve fibers stained with PGP9.5 in glands of DIE non-bowel only, but not in other sites and not in the stroma. These results may reflect the phenomenon of axonal pruning, through which BDNF may induce pruning in neurons and thus lead to a lower nerve fiber density in the tissue. Our results are consistent with those of Singh et al. who showed that BDNF via p75 receptor influenced the development of sympathetic axon pruning, despite the simultaneous presence of NGF at the same site .
We found no correlation between NGF and nerve fiber density, as also reported by others [45, 46]. NGF competes for the same axons as BDNF to determine the fate of nerve fibers/neurons. In in vitro studies, the pruning/apoptosis effects of BDNF override the growth effects of NGF. Induction of pruning is stronger than the induction of growth . This would explain why NGF-positive immunostaining did not correlate to a higher density of nerve fibers but instead there was a negative correlation between BDNF and nerve fiber density seen in DIE.
We did find a negative correlation between BDNF-positive staining and the density of nerve fibers stained with TH in the gland of non-bowel DIE. These results are consistent with the study by Krizsan-Agbas et al. which showed in a rat model that BDNF suppresses sympathetic neurite growth and that this effect is mediated by estrogen .
To our knowledge, ours is the first study to employ a semi-quantitative method to analyzing immunohistochemical staining in endometriosis . While the software used does not replace the skills and expertise of the experienced human observer (pathologist), it is gaining popularity in the research and clinical setting . The emergence of computerized image analysis systems for accurate analysis of immunohistochemistry specimen is increasingly needed. In breast cancer, a disease where the degree of estrogen receptor and progesterone receptor expression predicts outcome, Walker et al. argue that computerized image analysis systems present more accurate means of quantification. It is well accepted that manual counting is time consuming  and automated imaging methods are immune to fatigue and subjectivity .
The neurotrophins and their receptors are part of a complex signaling system that are present in endometriosis. We showed that endometriotic lesions, especially epithelial glandular cells and stromal cells, express neurotrophins BDNF and NGF and their receptors, TrkA, TrkB and p75. The spatial arrangement of these agonists and receptors suggests an autocrine function in endometriosis, though a clear causative picture does not emerge given the redundancy and complexity of the signaling system. BDNF has a stronger binding affinity than NGF to the p75 receptor, likely inducing sympathetic nerve axonal pruning in DIE, resulting in the lower nerve fiber density seen in DIE. The differences in neurotrophin expression between PE and DIE may reflect the differencing innervations and cell fates, namely growth and infiltration and have been shown to be hormone-mediated. Thus, in future studies, differences in local estrogen action as measured by the distribution of estrogen receptors in co-localization with the BDNF neurotrophin signaling system and the density of nerves should be evaluated to more closely delineate this complex system and to further explain differences between PE and DIE.
ASRM: American Society of Reproductive Medicine; BDNF: brain-derived neurotrophic factor; DAB: 3,3’-diaminobenzidine; DIE: deep infiltrating endometriosis; H&E: hematoxyline and eosin; NGF: nerve growth factor; NT-3: neurotrophins-3; NT-4: neurotrophins-4; NT-5: neurotrophins-5; PE: Peritoneal endometriosis; PGP9.5: Protein Gene Product 9.5; ROI: region of interest; TH: tyrosine hydroxylase; TNF: tumor necrosis factor; Trk: tropomyosin kinase
The antibody anti p75 was a kind gift from Professor Dr. Louis F. Reichardt from University of California, San Francisco, California.
There were no sources of external funding for this study.
Dr. Dewanto was supported by scholarships from the Indonesian Directorate General of Higher Education, Ministry of National Education, Indonesia; i-med Forschungsstipendien (Nachwuchsförderung), Medical University of Innsbruck, and ASEA-UNINET.
Availability of data and material
The dataset analysed during the study is available upon request from the corresponding author.
AD performed, analyzed and interpreted the histological examinations, performed statistical analyses and contributed to writing the manuscript; JD analyzed and interpreted the histological examinations, assisted with statistical analyses, and contributed to conceptualization of the study; RG analyzed and interpreted the histological examinations, assisted with statistical analyses, and contributed to conceptualization of the study; SM analyzed and interpreted the data, conceptualized the study and edited the manuscript for key content; ASF analyzed and interpreted the data, conceptualized the study and edited the manuscript for key content; LW analyzed and interpreted the data, conceptualized the study and edited the manuscript for key content; BS analyzed and interpreted the data, assisted with statistical analyses, conceptualized the study and was a major contributor to writing, editing and revising the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Subjects gave their informed consent for research participation.
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the Medical University of Innsbruck, UN5130, 02.08.2013.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med. 2014;2014:179515.View ArticlePubMedPubMed CentralGoogle Scholar
- Koninckx PR, et al. Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease. Ann N Y Acad Sci. 1994;734:333–41.View ArticlePubMedGoogle Scholar
- Tosti C, et al. Pathogenetic Mechanisms of Deep Infiltrating Endometriosis. Reprod Sci. 2015;22(9):1053–9.View ArticlePubMedGoogle Scholar
- Tokushige N, et al. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006;21(11):3001–7.View ArticlePubMedGoogle Scholar
- Mckinnon BD, et al. Inflammation and nerve fiber interaction in endometriotic pain. Trends Endocrinol Metab. 2015;26(1):1–10.View ArticlePubMedGoogle Scholar
- Mechsner S, et al. Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril. 2005;83 Suppl 1:1220–31.View ArticlePubMedGoogle Scholar
- Arnold J, et al. Neuroimmunomodulatory alterations in non-lesional peritoneum close to peritoneal endometriosis. Neuroimmunomodulation. 2013;20(1):9–18.View ArticlePubMedGoogle Scholar
- Wang G, et al. Rich innervation of deep infiltrating endometriosis. Hum Reprod. 2009;24(4):827–34.View ArticlePubMedGoogle Scholar
- Barcena De Arellano ML, et al. Evidence of neurotrophic events due to peritoneal endometriotic lesions. Cytokine. 2013;62(2):253–61.View ArticlePubMedGoogle Scholar
- Caporali A, Emanueli C. Cardiovascular actions of neurotrophins. Physiol Rev. 2009;89(1):279–308.View ArticlePubMedPubMed CentralGoogle Scholar
- Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.View ArticlePubMedPubMed CentralGoogle Scholar
- Tarjanne S, et al. Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis. Acta Obstet Gynecol Scand. 2015;94(7):693–700.View ArticlePubMedGoogle Scholar
- Anaf V, et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod. 2002;17(7):1895–900.View ArticlePubMedGoogle Scholar
- Arnold J, et al. Imbalance between sympathetic and sensory innervation in peritoneal endometriosis. Brain Behav Immun. 2012;26(1):132–41.View ArticlePubMedGoogle Scholar
- Kuteken FS, et al. Expression of neurotrophic and inflammatory mediators in rectosigmoid endometriosis. Rev Bras Ginecol Obstet. 2012;34(12):568–74.View ArticlePubMedGoogle Scholar
- Barcena De Arellano ML, et al. Eutopic endometrium from women with endometriosis does not exhibit neurotrophic properties. J Neuroimmunol. 2012;249(1–2):49–55.View ArticlePubMedGoogle Scholar
- Wessels JM, et al. Estrogen induced changes in uterine brain-derived neurotrophic factor and its receptors. Hum Reprod. 2015;30(4):925–36.View ArticlePubMedGoogle Scholar
- Wessels JM, et al. Assessing brain-derived neurotrophic factor as a novel clinical marker of endometriosis. Fertil Steril. 2016;105(1):119–28.View ArticlePubMedGoogle Scholar
- Liang Y, Yao S. Potential role of estrogen in maintaining the imbalanced sympathetic and sensory innervation in endometriosis. Mol Cell Endocrinol. 2016;424:42–9.View ArticlePubMedGoogle Scholar
- Browne AS, et al. Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis. Fertil Steril. 2012;98(3):713–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Wessels JM, et al. The brain-uterus connection: brain derived neurotrophic factor (BDNF) and its receptor (Ntrk2) are conserved in the mammalian uterus. PLoS One. 2014;9(4), e94036.View ArticlePubMedPubMed CentralGoogle Scholar
- Gallo G, Lefcort FB, Letourneau PC. The trkA receptor mediates growth cone turning toward a localized source of nerve growth factor. J Neurosci. 1997;17(14):5445–54.PubMedGoogle Scholar
- Brady R, et al. BDNF is a target-derived survival factor for arterial baroreceptor and chemoafferent primary sensory neurons. J Neurosci. 1999;19(6):2131–42.PubMedGoogle Scholar
- Lentz SI, et al. Neurotrophins support the development of diverse sensory axon morphologies. J Neurosci. 1999;19(3):1038–48.PubMedGoogle Scholar
- Bulun SE, et al. Aromatase and endometriosis. Semin Reprod Med. 2004;22(1):45–50.View ArticlePubMedGoogle Scholar
- Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Horm Mol Biol Clin Investig. 2011;5(2):125–42.PubMedGoogle Scholar
- Tokushige N, et al. Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis. Fertil Steril. 2009;92(4):1234–9.View ArticlePubMedGoogle Scholar
- Barcena De Arellano ML, et al. Neurotrophin expression is not affected in uteri of women with adenomyosis. J Mol Neurosci. 2012;47(3):495–504.View ArticlePubMedGoogle Scholar
- Kajitani T, et al. Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. Endocr J. 2013;60(10):1155–64.View ArticlePubMedGoogle Scholar
- Indo Y. Neurobiology of pain, interoception and emotional response: lessons from nerve growth factor-dependent neurons. Eur J Neurosci. 2014;39(3):375–91.View ArticlePubMedGoogle Scholar
- Farinas I, et al. Regulation of neurogenesis by neurotrophins in developing spinal sensory ganglia. Brain Res Bull. 2002;57(6):809–16.View ArticlePubMedGoogle Scholar
- Barcena De Arellano ML, Mechsner S. The peritoneum—an important factor for pathogenesis and pain generation in endometriosis. J Mol Med (Berl). 2014;92(6):595–602.Google Scholar
- Lagadec C, et al. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 2009;28(18):1960–70.View ArticlePubMedGoogle Scholar
- Davidson B, et al. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat. 2004;83(2):119–28.View ArticlePubMedGoogle Scholar
- Kawamura K, et al. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling. Cancer Med. 2013;2(6):849–61.View ArticlePubMedPubMed CentralGoogle Scholar
- Straub RH, et al. The role of the sympathetic nervous system in intestinal inflammation. Gut. 2006;55(11):1640–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Furness JB. The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol Motil. 2008;20 Suppl 1:32–8.View ArticlePubMedGoogle Scholar
- Su HC, et al. Dual intrinsic and extrinsic origins of CGRP- and NPY-immunoreactive nerves of rat gut and pancreas. J Neurosci. 1987;7(9):2674–87.PubMedGoogle Scholar
- Oh JT, et al. Morphometric evaluation of PGP9.5 and NCAM expressing nerve fibers in colonic muscle of patients with Hirschsprung’s disease. Yonsei Med J. 2002;43(1):31–6.View ArticlePubMedGoogle Scholar
- Southwell BR, et al. Decrease in nerve fibre density in human sigmoid colon circular muscle occurs with growth but not aging. Neurogastroenterol Motil. 2010;22(4):439–45. e106.View ArticlePubMedGoogle Scholar
- Tomita T. Localization of nerve fibers in colonic polyps, adenomas, and adenocarcinomas by immunocytochemical staining for PGP 9.5. Dig Dis Sci. 2012;57(2):364–70.View ArticlePubMedGoogle Scholar
- Sams VR, et al. Evaluation of PGP9.5 in the diagnosis of Hirschsprung’s disease. J Pathol. 1992;168(1):55–8.View ArticlePubMedGoogle Scholar
- Ferrero S, et al. Loss of sympathetic nerve fibers in intestinal endometriosis. Fertil Steril. 2010;94(7):2817–9.View ArticlePubMedGoogle Scholar
- Singh KK, et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat Neurosci. 2008;11(6):649–58.View ArticlePubMedGoogle Scholar
- Krizsan-Agbas D, et al. Oestrogen regulates sympathetic neurite outgrowth by modulating brain derived neurotrophic factor synthesis and release by the rodent uterus. Eur J Neurosci. 2003;18(10):2760–8.View ArticlePubMedGoogle Scholar
- Brauer MM, et al. The role of NGF in pregnancy-induced degeneration and regeneration of sympathetic nerves in the guinea pig uterus. J Auton Nerv Syst. 2000;79(1):19–27.Google Scholar
- Walker RA. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment I. Histopathology. 2006;49(4):406–10.View ArticlePubMedGoogle Scholar
- Schlederer M, et al. Reliable quantification of protein expression and cellular localization in histological sections. PLoS One. 2014;9(7), e100822.View ArticlePubMedPubMed CentralGoogle Scholar
- Taylor CR, Levenson RM. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49(4):411–24.View ArticlePubMedGoogle Scholar